Market Overview

Benzinga's Top Pre-Market Losers

Related HALO
Mid-Morning Market Update: Markets Gain; Johnson & Johnson Profit Beats Street View
Morning Market Movers
Halozyme Shares Plummet as Concerns Halt Trial (Fox Business)
Related ENTR
Benzinga's Top Downgrades
Benchmark Company Reiterates Buy on Entropic Communications Following Mixed Results

Halozyme Therapeutics (NASDAQ: HALO) dipped 20.68% to $6.75 in the pre-market session after the company provided update on ViroPharma Phase 2 study of subcutaneous Cinryze (C1 Esterase Inhibitor [Human]) with recombinant human hyaluronidase.

Entropic Communications (NASDAQ: ENTR) shares fell 16.48% to $3.70 in the pre-market trading after the company reported Q2 results. Benchmark downgraded Entropic from “buy” to “hold.”

Reliv International (NASDAQ: RELV) shares dropped 15.57% to $3.09 in pre-market trading after the company posted a Q2 net loss of $214,000, versus a year-ago net income of $103,000.

NII Holdings (NASDAQ: NIHD) dipped 6.94% to $6.70 in the pre-market session on second-quarter results.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Most Popular

Related Articles (ENTR + HALO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free